4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001447028-22-000007
Options or other derivatives
- Chief Business Officer acquired 325,850 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McElhaugh Michael J. · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +325,850 | $2.81 | $915,639 | 325,850 | D |
Loading xslF345X03/wf-form4_164271921610822.xml…